REGISTERED
on 15 Nov 2022
Last Applicant/ Owned by
601 Gateway Boulevard, Suite 350
South San Francisco
CA
94080
Serial Number
88088292 filed on 22nd Aug 2018
Registration Number
6901415 registered on 15th Nov 2022
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AKERO
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treat Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders
First Use Date in General
15th Mar 2022
First Use Date in Commerce
31st May 2022
Mark Details
Serial Number
No 88088292
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 32990/60004
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Nov 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 15th Nov 2022 | REGISTERED-PRINCIPAL REGISTER |
| 13th Oct 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 12th Oct 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th Sep 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 27th Sep 2022 | USE AMENDMENT FILED |
| 27th Sep 2022 | TEAS STATEMENT OF USE RECEIVED |
| 29th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Mar 2022 | SOU EXTENSION 5 GRANTED |
| 25th Mar 2022 | SOU EXTENSION 5 FILED |